New 80 million euro investment for the Athens LifeTech Park
A significant investment in the health and technology sector was recently announced in Greece. The pharmaceutical company ELPEN is proceeding with the creation of the "Athens LifeTech Park," a modern center for research and innovation.
The total value of the investment amounts to 80 million euros. This new park is set to become a hub for the development of new medicines and medical technologies, strengthening the country's presence on the global biomedical research map.
The creation of the Athens LifeTech Park is expected to offer new job opportunities for scientists and researchers in Greece. At the same time, the project aims to collaborate with universities and other research institutions, promoting the connection between academic knowledge and production.
With this move, ELPEN strengthens its role in the Greek economy, investing in innovation and extroversion. The project represents a significant step toward the modernization of the health sector in our country.